Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nitric Oxide ; 7(1): 50-6, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12175820

RESUMO

The hypotensive effect of RuNO was investigated in acute and chronic hypertensive rats, as well as in normotensive rats. Acute hypertension rats were used with 30% increase on basal BP (phenylephrine, angiotensin II (Ang II), N(G)-nitro-L-arginine methyl ester (L-NAME), and adult spontaneously hypertensive rats (SHR) (basal BP 168 +/- 3 mm Hg) were used as models for chronic hypertension. Rats were implanted with catheters (iv/ia) for BP measurements and for in bolus administration of RuNO, sodium nitroprusside (SNP), and acetylcholine (Ach) (10, 20, 40 nmol/kg, iv). The principal findings of this study were: (i) The hypotensive response to RuNO was 150% higher in acutely (phenylephrine and Ang II) and chronically (SHR) hypertensive rats than in normotensive rats, except in the case of L-NAME-induced hypertension (deltaMAP = 10 +/- 1.4 mm Hg). Chronic SHR showed 60% increase (deltaMAP = 19 +/- 0.8 mm Hg) in the effect compared to normotensive rats. (ii) The hypotensive response to SNP was lower (60%) in hypertensive rats than in normotensive rats, when compared to RuNO. However, the responses were similar in L-NAME-induced hypertension (deltaMAP = 30 +/- 2 mm Hg). (iii) The vasodilator response to Ach was increased in rats with Ang II-induced hypertension (deltaMAP = 53 +/- 1 mm Hg) and in SHR (deltaMAP = 67 +/- 3 mm Hg). RuNO response was more potent than SNP in hypertensive models and the increment in relation to normotensive was observed in the phenylephrine- and L-NAME-treated rats. This response could be correlated to the different endothelial dysfunction present in each model.


Assuntos
Modelos Animais de Doenças , Endotélio Vascular/fisiologia , Hipertensão/tratamento farmacológico , Doadores de Óxido Nítrico/farmacologia , Vasodilatadores/farmacologia , Acetilcolina/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Masculino , Doadores de Óxido Nítrico/administração & dosagem , Nitroprussiato/farmacologia , Compostos Organometálicos/administração & dosagem , Compostos Organometálicos/farmacologia , Ratos , Ratos Wistar , Compostos de Rutênio/administração & dosagem , Compostos de Rutênio/farmacologia , Vasodilatadores/administração & dosagem
2.
Nitric Oxide ; 6(3): 247-54, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12009842

RESUMO

The hypotensive effect and the acute toxicity of trans-[Ru(NH(3))(4)P(OEt)(3)(NO)](PF(6))(3) (RuNO) were investigated in conscious animals. The approximate lethal dose of RuNO is 257.5 micromol/kg in mice i.p. and the IC(50) values evaluated for V79 culture cell cytotoxicity were higher than 2.0 mM, suggesting that the ruthenium species are significantly less toxic than Na(2)[Fe(CN)(5)(NO)] (SNP) species. The RuNO hypotensive effect measured through in-bolus intravenous administration in chronically instrumented normotensive and hypotensive adult male Wistar rats is similar to that exhibited by equivalent doses of SNP. The hypotensive effect of the ruthenium complex is fully inhibited by methylene blue and PTIO, suggesting that the RuNO effect is likely to be primarily dependent on the NO-[cGMP] pathway in the smooth muscle cells.


Assuntos
Anti-Hipertensivos/farmacologia , Doadores de Óxido Nítrico/farmacologia , Doadores de Óxido Nítrico/toxicidade , Compostos Organometálicos/farmacologia , Compostos Organometálicos/toxicidade , Rutênio/farmacologia , Animais , Anti-Hipertensivos/toxicidade , Linhagem Celular , Cricetinae , Camundongos , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...